Frequently Asked Questions
Frequently Asked Questions about The CuraCator Clinical Method™
TOP 5 ADOPTION QUESTIONS
What is the CuraCator Clinical Method™?
The CuraCator Clinical Method™ is a physician-developed protocol for precision biologic delivery during regenerative aesthetic procedures.
It transforms application from passive dripping or manual spreading to controlled dispersion across the treatment surface — supporting:
• Reduced runoff
• Greater procedural precision
• Enhanced patient experience
• Improved consistency in biologic placement
We have advanced what we apply. Now we advance how we apply it.
How does CuraCator™ improve PRP and exosome delivery during microneedling?
Traditional application often relies on dripping PRP or exosomes directly onto the skin and spreading manually.
The CuraCator Clinical Method™ supports:
• Even surface distribution
• Reduced pooling and runoff
• Controlled dispersion through micropore technology
• Enhanced precision during microneedling and laser resurfacing
The result is a more refined and elevated procedural experience for both provider and patient.
Who should use the CuraCator Clinical Method™?
The CuraCator Clinical Method™ is designed for providers who prioritize precision and procedural excellence, including:
• Dermatologists
• Plastic surgeons
• Regenerative aesthetic physicians
• Advanced aesthetic practices performing PRP or exosome procedures
It is particularly valuable for practices seeking to elevate application standards and reduce unnecessary biologic waste.
What is the ROI of adopting the CuraCator Clinical Method™?
Biologics such as PRP and exosomes represent both clinical value and financial investment.
By supporting controlled dispersion and reducing runoff, the CuraCator Clinical Method™:
• Minimizes product waste
• Enhances surface coverage
• Creates opportunity to treat additional areas without increasing product volume
• Elevates perceived value of regenerative treatments
In real-world application, even small reductions in runoff can translate into meaningful value retention over time.
Precision is not just clinical — it is financial.
When should I introduce the CuraCator Clinical Method™ into my practice?
CuraCator™ integrates easily into any regenerative aesthetic protocol and can be adopted immediately.
Many providers begin using it during PRP microneedling and expand use to:
• Exosome-assisted microneedling
• Laser resurfacing
• Combination regenerative treatments
Adoption requires no additional equipment and enhances patient perception of advanced, precision-driven care.
WHAT EXPERTS ARE SAYING
CLINICAL & TECHNICAL QUESTIONS
What procedures is CuraCator™ commonly used for?
• PRP microneedling
• Exosome-assisted microneedling
• Laser resurfacing
• Combination regenerative protocols
What products can be dispensed through CuraCator™?
• PRP
• Exosomes
• Liquids
• Gels
• Creams
• Select topical biologics
What syringe size works best?
CuraCator™ attaches to any universal Luer-lock syringe up to 5mL.
3mL syringes are recommended for optimal procedural control.
Syringes not included.
Can I aspirate product through CuraCator™?
Yes.
Providers may aspirate directly through the CuraCator™ once attached to the syringe, or aspirate with a needle first and then attach the CuraCator™ for controlled application.
Does CuraCator™ alter the biologic?
No.
The device allows for smooth expression of product without altering product integrity.
Is CuraCator™ sterile?
Yes.
Each unit is individually packaged and sterilized using E-beam sterilization and intended for single use.
What is the shelf life?
CuraCator™ has a shelf life of 5 years when stored under standard conditions.
Is CuraCator™ FDA registered?
CuraCator™ is a registered Class I medical device manufactured in compliance with applicable FDA regulations.
Where is CuraCator™ manufactured?
CuraCator™ is manufactured in the United States using medical-grade materials.
How many units are in a box?
Each box contains 20 sterile, single-use CuraCator™ units.